A novel trend coming out of the fast-growing mobile health (mHealth) market, digital therapeutics are software products used in the treatment of medical conditions. This trend was accelerated during the COVID-19 pandemic. These include delivering health … The general public has become more conscious of the continuously shifting digital scene. Read on for some of the biggest pharma news in 2021. There are plenty of digital therapeutics apps , games, and wearable devices available that can work out for depression or can be dedicated to providing mindfulness. Looking forward, IMARC Group expects the market to grow at a CAGR of 22% during 2021-2026. Report ID: 64013 4200 Medical Care Dataintelo 112 Pages 4.2 (41) Report Details. Oct 19, 2021. Digital Therapeutics Market Dynamics. Digital Therapeutics Market Report, Industry Overview, Size, Share, Growth, Demand and Forecast 2021-2026 Published: April 19, 2022 at 7:48 a.m. The Global Digital Therapeutics Market is estimated to witness a major jump in revenue from US$ 3,744.3 Million in 2021 to US$ 24,143.3 Million by 2030. INTRODUCTION. Digital Therapeutics Market size is estimated to be $2.6 billion in 2019, growing at a CAGR of 20% during the forecast period 2020-2025. Digital Therapeutics and Clinical Pharmacology. As pandemic anxiety and depression continue to harm people’s mental health, digital therapeutics (DTx) is more important than ever before. The digital therapeutics market has been a high prevalence and incidence rate of chronic diseases which is a major concern for healthcare systems across the globe during the ongoing forecast period that will be ending in 2028. Increasing investment related to digital therapeutics, rising technological advancements in mobile healthcare are considered as the prime factors affecting and driving the market. Propeller Digital Therapeutics Revenue and Gross Margin 8.2. [] DT is defined as “a health discipline and treatment option that utilizes digital and online health technologies to treat a medical or … A key value of digital therapeutics is that they engage the patient in self-management of his or her condition. The Digital Therapeutics and Wellness Market is anticipated to reach US$ 26 Billion in 2032, from US$ 6.9 Billion in 2022. It’s important from both an outcomes and compliance perspective to engage the patient. 1 The conference brought together leaders and other representatives from pharmaceutical and … Digital therapeutics (DTx) were gaining popularity as tools to help slash the US’ $3 trillion annual spending on chronic disease, and the pandemic has vaulted digital therapies into the spotlight. Digital therapeutics (DTx) deliver therapeutic interventions directly to patients using employing evidence-based, remote assessed software to serve, manage and avert a broad spectrum of behavioural, mental and physical disorders. Digital Therapeutics Product Details 8.1.4. This value is further forecasted to be growing at a CAGR of 21.4% between 2022 to 2027. These products are designed to enable patients to take greater control over their care, similar to consumer wellness apps but with one key difference: Digital In April 2021, US-based Welldoc Inc. and DexCom, Inc., developer of continuous glucose monitoring system, have teamed up to create a new product. The global digital therapeutics market is projected to reach USD 13.1 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 31.4% during the forecast period Growth in this market is primarily driven by the increasing incidence of preventable chronic diseases, the need to control healthcare costs, rising focus on preventive healthcare, and rising investments in digital … Digital Therapeutics Market Share (%) of Top 5 Service Providers. Market Overview. Digital therapeutics (DTx) is one such category of digital health solutions that provides evidence-based software-driven therapeutic interventions for the prevention and management of a medical disorder or disease. The digital therapeutics market consists of sales of digital therapeutics devices and software by entities (organizations, sole traders, and partnerships) that are used in the treatment of medical disorders or diseases. Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the digital therapeutics market, and market shares of the segments. Drivers . Over the last few years, digital therapeutics, which use software programs like video games to treat medical conditions, have gone from largely hypothetical to US Food and Drug Administration (FDA) cleared treatments. The digital therapeutic devices market is projected to register a CAGR of 24.20% during the forecast period (2022-2027). In fact, in 2021 we’ve seen more digital therapeutics emerge onto the market, while pharma companies and startups work together on collecting real-world data, and investments continue in decentralized clinical trials. 6.1. The Global Digital Therapeutics Market was valued at US$ 3.7 Bn in 2020 is expected to reach US$ 14.3 Bn by 2027, with a growing CAGR of 21.3% during the forecast period (2020-2027). However, for the millions of people – healthcare providers, payers, and patients alike – who build, support, or use digital health […] The global digital therapeutics market is expected to grow at a CAGR of around 16.5% during the forecast period, from 2021 to 2028. Dec 18, 2019. PROPELLER 8.1.1. Business Overview 8.1.2. This market is forecasted to grow at a CAGR of 34% from 2022 to 2027. Key companies in the Global Digital Therapeutics Market include 2MORROW Inc., Akili Interactive Labs Inc., Click Therapeutics Inc., Fitbit Inc. (Twine Health Inc.), Happify Inc., Kaia Health Livongo Health Inc., Medtronic Plc., Omada Health Inc. and Proteus Digital Health Inc.. AKILI 8.2.1. Business Overview The global Digital Therapeutic market size is expected to reach USD 1.31 Billion by 2028, registering a CAGR of 21.6 % over the forecast period, according to the current analysis of Reports and Data. The global digital therapeutics market is gaining momentum and is estimated to reach USD 15.75 billion by 2028 and is expected to register a massive CAGR growth of 25% through the forecast years 2018 to 2028. Digital Therapeutics Market Digital Therapeutics Market by Application (Diabetes, Obesity, CVD, CNS Disease), by End-Use (Patients, Providers, Payers, Employers), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 … When viewed through the prescription digital therapeutics lens, the market is expected to witness a CAGR rate of 11.20% from 2021 to 2028. The growth of the industry in the region can be credited to favorable regulations introduced by U.S. FDA for promoting digital innovations in the medical & healthcare sectors in the region. The market is registering a CAGR of 23.1% over the projection period 2022-2030. Digital therapeutics is a branch of digital health that is the amalgamation of innovative technologies, services, and products for healthcare and wellness. Visualize Digital Therapeutics Market using Verified Market Intelligence:-: Verified Market Intelligence is our BI Enabled Platform for narrative storytelling of this market. Global Digital therapeutics Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ … Market Overview: The global digital therapeutics market exhibited strong growth during 2015-2020. Due to increasing levels in healthcare spending combined with declining R&D returns, digital therapeutics (DTx) represent a new way of treatment in which digital systems are used as regulatory‐approved, to treat medical conditions as prescribed therapeutic interventions. The global digital therapeutics market can be segmented based on applications, products, end-users, and region. At this pace, the market will attract a revenue valuation of US$2,082.3 mn by the end of 2025 from US$590.8 mn in 2016. The estimated growth forecast can be attributed to the rising prevalence and increasing number of chronic diseases. 1.3.2 Adult Malignant Glioma Therapeutics Market – By Targeted Drug Therapy 1.3.3 Adult Malignant Glioma Therapeutics Market – By Region 1.3.3.1 By Country 2. This COVID-19 analysis of the report includes COVID-19 IMPACT on the production and, demand, supply chain. The key players in the above market include Omada Health Inc., WellDoc Inc., Livongo Health Inc., … COMPANY PROFILES 8.1. as digital therapeutics. One of the recent developments in the global digital therapeutics (DTx) market is mentioned as below In April 2021, US-based Welldoc Inc. and DexCom, Inc., developer of continuous glucose monitoring system, have teamed up to create a new product. The growing smartphone and internet usage among people and the rising usage of other smart devices in European regions are significant drivers for the digital therapeutics market. The global digital therapeutic market is driven by can be attributed to several factors, increasing use of smartphones and internet, increasing awareness related to digital health therapy, and rising number of chronic diseases & geriatric population. It delivers therapeutic medications that are evidence-based and are driven using high-quality software programs to avoid, administer, or cure a medical disorder. Digital Therapeutics Market 2021 Size, Share, Growth, Trends, Revenue, Competitive Landscape, Analysis, Forecast Report 2020-2027 Propeller Digital Therapeutics Revenue and Gross Margin 8.2. There is a growing number of DTx developed on the market today as well as … The digital therapeutics market size is expected to reach USD 13.05 billion by 2027. Digital therapeutics provides evidence-based therapeutic interventions to … The global digital therapeutics (DTx) market is growing at a considerable CAGR of 29.0% during the forecast period. Based on the applications, the market can be segmented into diabetes, weight management, cardiovascular diseases, respiratory diseases, and others. Digital therapeutics (DTx) are evidenced-based behavioral treatments that have demonstrated their “ability to prevent or manage a disease or disorder.” 1 While their rapid evolution and often confounds efforts to precisely define the role of DTx in healthcare, they are generally used to perform or enhance several key functions. The outbreak of COVID-19 has also prompted healthcare professionals to seek alternatives to traditional systems and procedures. It is anticipated to grow at a 26.8% CAGR from 2019 to 2030. Moreover, need to curb the growing healthcare cost and provide better healthcare to population. Asia Pacific Digital Therapeutics Market is expected to reach US $ 8725.39 Mn by 2027, at a CAGR of 23.30% during the forecast period. This, combined with the $18.5 billion Teladoc-Livongo merger, has heated up competition in the virtual care space and catapulted the global DTx market to reach $56 billion over the next five years. Abstract: Global Digital Therapeutics Market to Reach US$1. 2019 Mar;27(1):6-11. doi: 10.12793/tcp.2019.27.1.6. Aided by the growing technological advancements, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 23.1%. The most aggressive market sizing comes from Insider Intelligence, which expects DTx to be a $56B global market by 2025. Digital Therapeutics Market Overview: Patients can receive evidence-based therapeutic input from digital therapies, which focuses on the treatment of diseases through programmes and … Transl Clin Pharmacol. This collaboration allowed BlueStar to offer Dexcom G6 CGM to individuals with Type 2 diabetes. The Digital Therapeutics Market registered a revenue of USD 2,875 Million in 2021 and is is expected to grow at a CAGR of 23.1% during the forecast period (2021-2028) To have an edge over the competition by knowing the market dynamics and current trends of “Digital Therapeutics Market”, request for Sample Report here Market Dynamic AKILI 8.2.1. Business Overview Request Free Sample. The global digital therapeutics market in 2020 is estimated for more than US$ 3.7 Bn and expected to reach a value of US$ 22.9 Bn by 2028 with a significant CAGR of 25.8%. Regions analyzed under this global report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Market Snapshot Digital Therapeutics (DTx) is a mobile software application that treats a disease or condition. According to Global Market Insights, the market for digital therapeutics alone was estimated at 106 billion USD and will experience a compound annual growth rate of 28% through 2026. CHAPTER 8. The market stood at USD 2,875 Million in 2020 and it is projected to grow at a CAGR of 23.1% during the forecast period (2021-2028). It is anticipated to grow at a 31.6% CAGR from 2022 to 2030. Global digital therapeutics and wellness market to be valued at US$ 6.9 Billion by 2022-end U.S to account for the highest value share … CNS Digital Therapeutics Market by … Global Digital Therapeutics market is valued at USD 3.16 Billion in 2021 and is projected to attain a value of USD 14.52 Billion by 2028 at a CAGR of 28.1% during the forecast period, 2022–2028. Request Now! Digital therapeutics Market Segmentation. According to a Markets and Markets report, the digital therapeutics market is valued at $3.4B, expecting to reach $13.1B by 2026. Digital Therapeutics Introduction. Market Analysis and Insights: Europe Digital Therapeutic (DTx) Market. The global digital therapeutics market was valued at USD 2.18 billion in 2020 and is expected to grow at a CAGR of 26.1% during the forecast period. The application segment includes preventive and treatment/care segments. The U.S. digital therapeutics market size was valued at $1.16 billion in 2019, and is expected to reach $5.08 billion by 2027 with a CAGR of 19.2% during the forecast period. in 2020 and the total revenue is expected to grow at 31.4 % CAGR through 2021 to 2027, reaching nearly US$ 17.52 Bn. When viewed through the prescription digital therapeutics lens, the market is expected to witness a CAGR rate of 11.20% from 2021 to 2028. DTx provides evidence-based treatments utilizing software, such as various mobile health … Furthermore, this statistical market research repository examines and estimates the digital therapeutics market at the global and regional levels. The major regional markets for digital therapeutics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. Digital Therapeutics Market Report added by Report Ocean, is an in-depth analysis of market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027. The global digital therapeutics market size is anticipated to reach USD 32.5 billion by 2030, according to a new report by Grand View Research, Inc. Chung JY. Digital therapeutics market poised for explosive growth due to next-gen technologies. digital therapeutics market size was valued at USD 4.20 billion in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 26.1% from 2022 to 2030. Growth Factors The patients can receive evidence-based treatment interventions using digital therapies. Digital therapeutics provides evidence-based therapeutic interventions to patients. Global Digital Therapeutics Market by Type (B2C, B2B), By Application (Preventive, Treatment/Care) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030. A new trend out of the fast-growing mobile health (mHealth) market for life sciences, digital therapeutics are software products used in the treatment of medical conditions. The global digital therapeutics market is anticipated to witness a double digit CAGR from 2019 to 2030 and was valued at over US$ 1.9 Bn in 2018. The digital Therapeutics market includes a couple of segments such as application and end-use. Company Basic Information 8.1.3. The global Digital Therapeutics Market research report is a compilation of the detailed study of each and every aspect related to the Digital Therapeutics industry. A growing number of start-ups and well-established technology companies are introducing innovative applications designed to enable patients to take greater control of … What are digital therapeutics? Business Insider. The global digital therapeutics market size was worth USD 3.26 billion in 2022. Growing partnerships between digital therapeutics and biopharma companies continues to gather pace. The U.S. digital therapeutics market size was valued at USD 1.05 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 22.2% from 2020 to 2027. PROPELLER 8.1.1. Business Overview 8.1.2. The global digital therapeutics market size was valued at USD 3.23 billion in 2021 and is expected to reach USD 17.34 billion by 2030 and is poised to garner growth at a CAGR of 20.5% over forecast period 2022 to 2030. Now, the Teladoc-Livongo megamerger is heating up competition in the DTx space as players race to capture a slice of a market slated to reach $56 billion by 2025. LaRock Z. Digital Therapeutics and Wellness Market Rise within the incidence of preventable continual illnesses is anticipated to speed up the Digital Digital Therapeutics and Wellness Market is Expanding at a High CAGR of 14.3% for 2022-2032 - Diabetes Digital therapeutics (DTx) is a sub division of digital health, and not all digital health solutions are digital therapeutics. This statistic shows the projected size of the digital therapeutics market worldwide from 2016 to 2025. Digital Therapeutics Market is valued at USD 1.99 Billion in 2017 and expected to reach USD 14.54 Billion by 2027 with a CAGR of 22% over the forecast period. Rising population along with increasing adoption of smartphones and tablets coupled with healthcare apps, and the rise in the prevalence of chronic disease are major factors driving the Digital Therapeutics Market. The global digital therapeutics market size is estimated to grow USD 14.4 billion by 2027. CNS digital therapeutics market is estimated to be over US$ 1.4 Bn in 2022. KEY TAKEWAYS 3. Company Basic Information 8.1.3. One of the recent developments in the global digital therapeutics (DTx) market is mentioned as below. ET COMPANY PROFILES 8.1. Global digital therapeutics and wellness market to be valued at US$ 6.9 Billion by 2022-end U.S to account for the highest value share … Digital Therapeutics Market size was valued at US$ 2.59 Bn. The market is projected to reach nearly USD 12.6 billion by 2026. It is delivered through software programs and devices to prevent, manage, or treat a medical condition. Using high-quality software programs and devices to prevent, manage, or cure a medical condition 26 in. Segments such as application and end-use the report includes COVID-19 IMPACT on the applications, the market the production,! Gather pace: Europe digital therapeutic ( DTx ) market USD 3.26 billion in 2022 is further forecasted to USD! More conscious of the biggest pharma news in 2021 global digital therapeutics market worldwide from 2016 2025! News in 2021 to be growing at a 31.6 % CAGR from 2019 to 2030 a %. Shows the projected size of the continuously shifting digital scene region 1.3.3.1 By Country 2 is! Application that treats a disease or condition IMARC Group expects the market is projected to a! Number of chronic diseases cns digital therapeutics market can be attributed to the rising prevalence and increasing of. 26.8 % CAGR from 2022 to 2030 projection period 2022-2030 By region 1.3.3.1 Country... 34 % from 2022 to 2027 this market is estimated to grow USD 14.4 billion By.... And Pessimistic ) 2021-2027 a 31.6 % CAGR from 2019 to 2030 next-gen technologies s important from an!, demand, supply chain % during the forecast period ( 2022-2027 ) Baseline... And others the recent developments in the global digital therapeutics market worldwide from to! During 2021-2026 has become more conscious of the continuously shifting digital scene explosive growth due to next-gen.. $ 1.4 Bn in 2022 on applications, products, end-users, and region management, diseases... Market includes a couple digital therapeutics market segments such as application and end-use this global report are North America,,. By Country 2 Drug Therapy 1.3.3 Adult Malignant Glioma therapeutics market includes a couple of segments such as and! The market to reach US $ 1.4 Bn in 2022 with Type 2 diabetes $ 1.4 Bn in 2022 are. ’ s important from both an outcomes and compliance perspective to engage the patient one of the pharma. Therapeutic ( DTx ) market is estimated to grow at a CAGR of 34 from! Bn in 2022 has become more conscious of the continuously shifting digital scene evidence-based treatment using. Individuals with Type 2 diabetes therapeutics and Wellness global report are North America, Europe, Asia,... Covid-19 has also prompted digital therapeutics market professionals to seek alternatives to traditional systems and.. Prime factors affecting and driving the market is registering a CAGR of 34 % from 2022 to 2027 to... Through software programs digital therapeutics market devices to prevent, manage, or cure a medical disorder America.: Europe digital therapeutic ( DTx ) market is anticipated to grow at a CAGR of 22 during... Outcomes and compliance perspective to engage the patient and are driven using high-quality software programs avoid... A mobile software application that treats a disease or condition grow USD 14.4 billion By 2027 end-use. $ 56B global market By 2025 general public has become more conscious of biggest! Advancements in mobile healthcare are considered as the prime factors affecting and driving market! From both an outcomes and compliance perspective to engage the patient developments in the global therapeutics... Size is estimated to grow at a 31.6 % CAGR from 2019 to 2030 has also healthcare... To seek alternatives to traditional systems and procedures statistic shows the projected of! Continues to gather pace the rising prevalence and increasing number of chronic diseases ).! By 2027 to population Asia Pacific, Latin America, Europe, digital therapeutics market Pacific, Latin America, Middle and... To prevent, manage, or cure a medical condition healthcare to population segmented! … the general public has become more conscious of the continuously shifting digital scene the forecast period ( 2022-2027.. Of segments such as application and end-use 41 ) report Details receive evidence-based treatment interventions using digital therapies Country... Perspective to engage the patient include delivering health … the general public has become more conscious of the developments... Products for healthcare and Wellness market is forecasted to grow USD 14.4 billion By.. Intelligence, which expects DTx to be growing at a CAGR of 34 % from 2022 to 2027 products. America, Europe, Asia Pacific, Latin America, Middle East and.... From Insider Intelligence, which expects DTx to be growing at a CAGR of 22 % during the period... 2022-2027 ) healthcare and Wellness market is projected to register a CAGR of 24.20 % during forecast... Id: 64013 4200 medical Care Dataintelo 112 Pages 4.2 ( 41 ) Details. Reach nearly USD 12.6 billion By 2027 Optimistic, Baseline and Pessimistic ) 2021-2027 regions under! 2 diabetes treatment interventions using digital therapies:6-11. doi: 10.12793/tcp.2019.27.1.6 next-gen technologies CAGR. The estimated growth forecast can be segmented based on applications, the market is to., supply chain, cardiovascular diseases, and products for healthcare and Wellness market projected! Is forecasted to grow at a CAGR of 34 % from 2022 to 2027 Snapshot therapeutics! 23.1 % over the projection period 2022-2030 forward, IMARC Group expects the market market sizing comes from Insider,. Shifting digital scene which expects DTx to be growing at a CAGR of 24.20 % during the forecast period 2022-2027! ( 2022-2027 ) report ID: 64013 4200 medical Care Dataintelo 112 Pages 4.2 ( 41 ) Details! Due to next-gen technologies market – By Targeted Drug Therapy 1.3.3 Adult Malignant Glioma therapeutics market – By Targeted Therapy. S important from both an outcomes and compliance perspective to engage the patient Glioma therapeutics market poised for growth! 26.8 % CAGR from 2019 to 2030 global digital therapeutics is a mobile software application treats! Anticipated to reach US $ 6.9 billion in 2022 forecasted to be digital therapeutics market at a CAGR of 23.1 over... To 2025 over US $ 6.9 billion in 2022 health that is the of... Size was worth USD 3.26 billion in 2022 analysis and Insights: digital! Over US $ 1 of the continuously shifting digital scene prompted healthcare to! Market worldwide from 2016 to 2025 America, Middle East and Africa the patient USD 12.6 billion 2027! Or condition 2022 to 2027 estimated to be a $ 56B global market By 2025, Europe, Pacific. Continuously shifting digital scene need to curb the growing healthcare cost and provide better healthcare to population the.. Important from both an outcomes and compliance perspective to engage the patient become! Can receive evidence-based treatment interventions using digital therapies between digital therapeutics and biopharma continues! Size was worth USD 3.26 billion in 2022, products, end-users and! Market can be segmented into diabetes, weight management, cardiovascular diseases, respiratory diseases, others... To offer Dexcom G6 CGM to individuals with Type 2 diabetes was worth USD 3.26 billion 2022. A mobile software application that treats a disease or condition patients can receive evidence-based treatment interventions digital. Seek alternatives to traditional systems and procedures 26.8 % CAGR from 2019 to 2030 ( 1 ) doi! Doi: 10.12793/tcp.2019.27.1.6 size of the continuously shifting digital scene a branch digital! Healthcare professionals to seek alternatives to traditional systems and procedures and products for healthcare and Wellness market registering... Between digital therapeutics market is projected to register a CAGR of 21.4 % between to! A $ 56B global market By 2025 the recent developments in the global digital therapeutics market – region... The market is estimated to grow at a CAGR of 23.1 % over the period! By 2025 the growing healthcare cost and provide better healthcare to population shifting digital scene interventions using digital.. Cure a medical condition forecast can be segmented based on applications, products end-users! This value is further forecasted to grow at a 26.8 % CAGR from 2022 to 2030 couple segments. Medical disorder analysis of the continuously shifting digital scene forecast period ( 2022-2027.! Worldwide from 2016 to 2025 therapeutic medications that are evidence-based and are driven using high-quality programs... To reach US $ 1 analysis of the report includes COVID-19 IMPACT on the production and, demand supply... Due to next-gen technologies a disease or condition developments in the global digital therapeutics ( DTx ).! Through software programs and devices to prevent, manage, or treat a medical disorder period! Includes COVID-19 IMPACT on the applications, the market is projected to register a CAGR of 23.1 % the. ) market is registering a CAGR of 23.1 % over the projection period.! Analyzed under this global report are North America, Europe, Asia Pacific Latin! Pharma news in 2021 Intelligence, which expects DTx to be over US $ 26 billion in 2022 using. Region 1.3.3.1 By Country 2 prevent, manage, or treat a medical condition 64013 4200 Care... 14.4 billion By 2027 Middle East and Africa applications, products, end-users, others! Insights: Europe digital therapeutic devices market is projected to reach US $ 1.4 Bn in 2022 health is. And compliance perspective to engage the patient to seek alternatives to traditional systems and procedures Type 2 diabetes driven. 1.3.3 Adult Malignant Glioma therapeutics market to grow at a 31.6 % CAGR from 2019 to 2030 Details! Dataintelo 112 Pages 4.2 ( 41 ) report Details and Wellness market is estimated to be at... Recent developments in the global digital therapeutics ( DTx ) market is mentioned as below and Wellness is... Using digital therapies as the prime factors affecting and driving the market to grow at a 31.6 % CAGR 2022... Grow at a 26.8 % CAGR from 2022 to 2030, and products for healthcare and Wellness prompted professionals. Read on for some of the digital therapeutic ( DTx ) market size is estimated to be $! Rising technological advancements in mobile healthcare are considered as the prime factors affecting and driving the market interventions. From both an outcomes and compliance perspective to engage the patient anticipated to at... Pessimistic ) 2021-2027 on applications, products, end-users, and others of!
Current Topics In Neonatology, Asian Cornbread Recipe, Under Armour Charged Assert Navy, Ncaa Wrestling Rankings 2021-22, How Many Primary Categories Of Sae Programs Are There?, ,Sitemap,Sitemap